Farther Finance Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1K | Sell |
433
-39
| -8% | -$1.54K | ﹤0.01% | 2771 |
|
|
2025
Q1 | $12.9K | Sell |
472
-179
| -27% | -$4.88K | ﹤0.01% | 2610 |
|
|
2024
Q4 | $22.8K | Buy |
651
+30
| +5% | +$1.05K | ﹤0.01% | 2030 |
|
|
2024
Q3 | $24.9K | Buy |
621
+58
| +10% | +$2.32K | ﹤0.01% | 1978 |
|
|
2024
Q2 | $26.5K | Sell |
563
-6
| -1% | -$283 | ﹤0.01% | 1671 |
|
|
2024
Q1 | $25K | Hold |
569
| – | – | ﹤0.01% | 1422 |
|
|
2023
Q4 | $28.8K | Buy |
569
+329
| +137% | +$16.6K | ﹤0.01% | 1224 |
|
|
2023
Q3 | $10.9K | Sell |
240
-7
| -3% | -$318 | ﹤0.01% | 1264 |
|
|
2023
Q2 | $10.1K | Buy |
247
+91
| +58% | +$3.73K | ﹤0.01% | 1189 |
|
|
2023
Q1 | $5.58K | Sell |
156
-3
| -2% | -$107 | ﹤0.01% | 1308 |
|
|
2022
Q4 | $6.01K | Buy |
+159
| New | +$6.01K | ﹤0.01% | 1106 |
|